An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19

SARS-CoV-2 is a new member of the coronavirus family and caused the pandemic of coronavirus disease 2019 (COVID-19) in 2020. It is crucial to design and produce an effective vaccine for the prevention of rapid transmission and possible deaths wcaused by the disease. Although intensive work and research are being carried out all over the world to develop a vaccine, an effective and approved formulation that can prevent the infection and limit the outbreak has not been announced yet. Among all types of vaccines, epitope-based peptide vaccines outshine with their low-cost production, easy modification in the structure, and safety. In this review, vaccine studies against COVID-19 have been summarized and detailed information about the epitope-based peptide vaccines against COVID-19 has been provided. We have not only compared the peptide vaccine with other types of vaccines but also presented comprehensive literature information about development steps for an effective and protective formulation to give an insight into on-going peptide vaccine studies against SARS-CoV-2.

___

  • Abdelmageed M. I., 2020, DESIGN MULTIEPITOPE, DOI [10.1101/2020.02.04.934232, DOI 10.1101/2020.02.04.934232]
  • Acar T, 2019, INT J PEPT RES THER, V25, P911, DOI 10.1007/s10989-018-9739-0
  • Ahmed SF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030254
  • Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w
  • Almofti YA., 2018, AMERJ MICROBIOL RES, V6, P94
  • Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007
  • [Anonymous], 2020, USINEWS 04 US IN EU .
  • Bahrami AA, 2019, INT REV IMMUNOL, V38, P307, DOI 10.1080/08830185.2019.1657426
  • Baruah V, 2020, J MED VIROL, V92, P495, DOI 10.1002/jmv.25698
  • Behrendt R, 2016, J PEPT SCI, V22, P4, DOI 10.1002/psc.2836
  • Bhattacharya M, 2020, J MED VIROL, V92, P618, DOI 10.1002/jmv.25736
  • Bojin F., 2020, DESIGN EPITOPE BASED .
  • Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1
  • Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361
  • Callaway E, 2020, NATURE, V580, P576, DOI 10.1038/d41586-020-01221-y
  • CAO XR, 2020, LUMINESCENCE 0115, DOI DOI 10.1126/SCIENCE.ABC1932
  • Cascella M., 2020, FEATURES EVALUATION .
  • Chan W, 1999, FMOC SOLID PHASE PEP .
  • Channappanavar R, 2014, IMMUNOL RES, V59, P118, DOI 10.1007/s12026-014-8534-z
  • Chen WH, 2020, CURR TROP MED REP, V7, P61, DOI 10.1007/s40475-020-00201-6
  • Cho H, 2018, HUM VACC IMMUNOTHER, V14, P304, DOI 10.1080/21645515.2017.1389362
  • Enjuanes L., 1995, Corona- and related viruses: current concepts in molecular biology and pathogenesis Laval, Quebec, Canada 27 August-1 September 1994., P197
  • Fast E, 2020, POTENTIAL T CELL B C, DOI [10.1101/2020.02.19.955484, DOI 10.1101/2020.02.19.955484]
  • Feng Y., 2020, BIORXIV, DOI DOI 10.1101/2020.03.03.962332
  • Glenny AT, 1926, J PATHOL BACTERIOL, V29, P31, DOI 10.1002/path.1700290106
  • Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015
  • Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002
  • Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0
  • Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681
  • Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
  • Hyun-Jung Lee Chloe, 2020, F1000Res, V9, P145, DOI [10.12688/f1000research.22507.2, 10.12688/f1000research.22507.1]
  • Jensen KJ, 2013, METHODS MOL BIOL, V1047, P1, DOI 10.1007/978-1-62703-544-6
  • Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
  • Joshi Amit, 2020, Inform Med Unlocked, V19, P100338, DOI 10.1016/j.imu.2020.100338
  • Kalita P, 2020, MICROB PATHOGENESIS, V145, DOI 10.1016/j.micpath.2020.104236
  • Kam YW, 2007, VACCINE, V25, P729, DOI 10.1016/j.vaccine.2006.08.011
  • Khan MT., 2019, SCI REP-UK, V9, P1, DOI DOI 10.1038/S41598-019-49354-Z
  • Khong H, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0160-y
  • Kibria K, 2020, MULTIEPITOPE VACCINE .
  • Kin N, 2015, VIRUSES-BASEL, V7, P2358, DOI 10.3390/v7052358
  • King AM, 2011, NUCLEIC ACIDS RES, V4, pD708, DOI [10.1093/nar/gkx932, DOI 10.1093/NAR/GKX932]
  • Kiyotani K, 2020, J HUM GENET, V65, P569, DOI 10.1038/s10038-020-0771-5
  • KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
  • Kumar S, 2020, CORONAVIRUS DIS, V2019, P43, DOI [10.1007/978-981-15-4814-7_5, DOI 10.1007/978-981-15-4814-7_5]
  • Li L, 2020, BIORXIV, DOI [10.1101/2020.02.25.965434, DOI 10.1101/2020.02.25.965434]
  • Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515
  • Li XW, 2020, J PHARM ANAL, V10, P102, DOI 10.1016/j.jpha.2020.03.001
  • Lin Y, 2003, CELL RES, V13, P141, DOI 10.1038/sj.cr.7290158
  • Lixin L, 2020, TRANSLATABLE SUBUNIT .
  • Lon J.R., 2020, BIORXIV, DOI [10.1101/2020.04.03.022723, DOI 10.1101/2020.04.03.022723]
  • Lu S, 2020, EMERG MICROBES INFEC, V9, P542, DOI 10.1080/22221751.2020.1737580
  • Ma CQ, 2020, MICROBES INFECT, V22, P245, DOI 10.1016/j.micinf.2020.05.004
  • Magnusson SE, 2018, IMMUNOL RES, V66, P224, DOI 10.1007/s12026-018-8991-x
  • Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0
  • MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025
  • Moisa AA, 2012, INSIGHT CONTROL INFE, P201
  • Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011
  • Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9
  • Navas-Martin S, 2003, VIRAL IMMUNOL, V16, P461, DOI 10.1089/088282403771926292
  • Nomura R, 2004, J VIROL, V78, P8701, DOI 10.1128/JVI.78.16.8701-8708.2004
  • Oany AR, 2014, DRUG DES DEV THER, V8, P1139, DOI [10.2147/DDDT.567861, 10.2147/DDDT.S67861]
  • Ohno S, 2009, VACCINE, V27, P3912, DOI 10.1016/j.vaccine.2009.04.001
  • Ozkan K, 2020, J PURE APPL MICROBIO, V14
  • Pant S, 2021, J BIOMOL STRUCT DYN, V39, P2904, DOI 10.1080/07391102.2020.1757510
  • Parvizpour S, 2020, DRUG DISCOV TODAY, V25, P1034, DOI 10.1016/j.drudis.2020.03.006
  • Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x
  • Pourseif MM, 2019, BIOIMPACTS, V9, P131, DOI 10.15171/bi.2019.18
  • Powell BS, 2015, CLIN EXP VACCINE RES, V4, P23, DOI 10.7774/cevr.2015.4.1.23
  • Rauch S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01963
  • Ravichandran S, 2020, BIORXIV, DOI [10.1101/2020.05.12.091918, DOI 10.1101/2020.05.12.091918]
  • Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006
  • Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674
  • Roper RL, 2009, EXPERT REV VACCINES, V8, P887, DOI 10.1586/ERV.09.43
  • Saif LJ., 2020, EMJ, DOI [10.33590/emj/200324, DOI 10.33590/EMJ/200324]
  • Sanchez-Trincado JL, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/2680160
  • SESARDIC D, 1993, J MED MICROBIOL, V39, P241, DOI 10.1099/00222615-39-4-241
  • Shang WL, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0170-0
  • Shereen MA, 2020, J ADV RES, V24, P91, DOI 10.1016/j.jare.2020.03.005
  • Shi JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144475
  • Sobolev BN, 2005, CURR COMPUT-AID DRUG, V1, P207, DOI 10.2174/1573409053585681
  • Stawikowski Maciej, 2012, Curr Protoc Protein Sci, VChapter 18, DOI 10.1002/0471140864.ps1801s69
  • Swee LK, 2013, P NATL ACAD SCI USA, V110, P1428, DOI 10.1073/pnas.1214994110
  • Tang T, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104792
  • Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5
  • Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001
  • Tomar Namrata, 2014, Methods Mol Biol, V1184, P23, DOI 10.1007/978-1-4939-1115-8_3
  • Tomar N, 2010, IMMUNOLOGY, V131, P153, DOI 10.1111/j.1365-2567.2010.03330.x
  • Tseng CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035421
  • Ucar B, 2019, PEPTIDE SYNTHESIS .
  • van Doremalen Neeltje, 2020, bioRxiv, DOI 10.1101/2020.05.13.093195
  • Veugelers R, 2020, RACING COVID 19 VACC .
  • Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006
  • Wang N, 2020, J INORG ORGANOMET P, V30, P4203, DOI 10.1007/s10904-020-01572-z
  • Wang YD, 2004, J VIROL, V78, P5612, DOI 10.1128/JVI.78.11.5612-5618.2004
  • Wu SC, 2020, BIOTECHNOL J, V15, DOI 10.1002/biot.202000147
  • Yang H, 2015, ADV PROTEIN CHEM STR, V99, P1, DOI 10.1016/bs.apcsb.2015.03.001
  • Yong CY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01781
  • Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284
  • Zhang G, 2020, BIORXIV, DOI [10.1101/2020.03.19.999318, DOI 10.1101/2020.03.19.999318]
  • Zhang JY, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020153
  • Zhang NR, 2020, MICROBES INFECT, V22, P231, DOI 10.1016/j.micinf.2020.05.001
  • Zhang XL, 2020, INT J INFECT DIS, V94, P81, DOI 10.1016/j.ijid.2020.03.040
  • Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9
  • Zhao K, 2011, VACCINE, V29, P6670, DOI 10.1016/j.vaccine.2011.06.100
  • Zhou GY, 2020, INT J BIOL SCI, V16, P1718, DOI 10.7150/ijbs.45123